124 related articles for article (PubMed ID: 33229118)
21. Discovery and synthesis of 3- and 21-substituted fusidic acid derivatives as reversal agents of P-glycoprotein-mediated multidrug resistance.
Guo M; Ren Q; Wang B; Ji W; Ni J; Feng Y; Bi Y; Tian J; Wang H
Eur J Med Chem; 2019 Nov; 182():111668. PubMed ID: 31505451
[TBL] [Abstract][Full Text] [Related]
22. Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index.
Bai J; Wang RH; Qiao Y; Wang A; Fang CJ
Drug Des Devel Ther; 2017; 11():2227-2237. PubMed ID: 28814831
[TBL] [Abstract][Full Text] [Related]
23. Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein.
Cao X; Li R; Xiong H; Su J; Guo C; An T; Zong H; Zhao R
Eur J Med Chem; 2021 Oct; 221():113520. PubMed ID: 34029775
[TBL] [Abstract][Full Text] [Related]
24. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and biological evaluation of N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-4-oxo-3,4-dihydrophthalazine-1-carboxamide derivatives as novel P-glycoprotein inhibitors reversing multidrug resistance.
Qiu Q; Zhou J; Shi W; Kairuki M; Huang W; Qian H
Bioorg Chem; 2019 May; 86():166-175. PubMed ID: 30710850
[TBL] [Abstract][Full Text] [Related]
26. MDR reversal and pro-apoptotic effects of statins and statins combined with flavonoids in colon cancer cells.
Palko-Łabuz A; Środa-Pomianek K; Wesołowska O; Kostrzewa-Susłow E; Uryga A; Michalak K
Biomed Pharmacother; 2019 Jan; 109():1511-1522. PubMed ID: 30551403
[TBL] [Abstract][Full Text] [Related]
27. Quercetin-glutamic acid conjugate with a non-hydrolysable linker; a novel scaffold for multidrug resistance reversal agents through inhibition of P-glycoprotein.
Kim MK; Kim Y; Choo H; Chong Y
Bioorg Med Chem; 2017 Feb; 25(3):1219-1226. PubMed ID: 28043777
[TBL] [Abstract][Full Text] [Related]
28. Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
Vágvölgyi M; Martins A; Kulmány Á; Zupkó I; Gáti T; Simon A; Tóth G; Hunyadi A
Eur J Med Chem; 2018 Jan; 144():730-739. PubMed ID: 29291440
[TBL] [Abstract][Full Text] [Related]
29. Pyxinol bearing amino acid residues: Easily achievable and promising modulators of P-glycoprotein-mediated multidrug resistance.
Wang C; Gao M; Liu S; Zou Z; Ren R; Zhang C; Xie H; Sun J; Qi Y; Qu Q; Song Z; Yang G; Wang H
Eur J Med Chem; 2021 Apr; 216():113317. PubMed ID: 33706147
[TBL] [Abstract][Full Text] [Related]
30. O
Li Q; Zou P; Sun J; Chen L
Eur J Med Chem; 2018 Jan; 143():732-744. PubMed ID: 29220794
[TBL] [Abstract][Full Text] [Related]
31. 1-[4-(2-Aminoethoxy)phenylcarbonyl]-3,5-bis-(benzylidene)-4-oxopiperidines: a novel series of highly potent revertants of P-glycoprotein associated multidrug resistance.
Das U; Molnár J; Baráth Z; Bata Z; Dimmock JR
Bioorg Med Chem Lett; 2008 Jun; 18(12):3484-7. PubMed ID: 18513966
[TBL] [Abstract][Full Text] [Related]
32. Exploratory chemistry toward the identification of a new class of multidrug resistance reverters inspired by pervilleine and verapamil models.
Teodori E; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Martelli C; Romanelli MN; Scapecchi S; Sudwan P; Salerno M
J Med Chem; 2005 Nov; 48(23):7426-36. PubMed ID: 16279802
[TBL] [Abstract][Full Text] [Related]
33. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells.
Xu SW; Law BYK; Qu SLQ; Hamdoun S; Chen J; Zhang W; Guo JR; Wu AG; Mok SWF; Zhang DW; Xia C; Sugimoto Y; Efferth T; Liu L; Wong VKW
Pharmacol Res; 2020 Mar; 153():104660. PubMed ID: 31982489
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis, and discovery of ocotillol-type amide derivatives as orally available modulators of P-glycoprotein-mediated multidrug resistance.
Ren Q; Yang G; Guo M; Guo J; Li Y; Lu J; Yang Q; Tang H; Li Y; Fang X; Sun Y; Qi JG; Tian J; Wang H
Eur J Med Chem; 2019 Jan; 161():118-130. PubMed ID: 30347326
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.
Aridoss G; Zhou B; Hermanson DL; Bleeker NP; Xing C
J Med Chem; 2012 Jun; 55(11):5566-81. PubMed ID: 22582991
[TBL] [Abstract][Full Text] [Related]
36. Jatrophane Diterpenoids as Modulators of P-Glycoprotein-Dependent Multidrug Resistance (MDR): Advances of Structure-Activity Relationships and Discovery of Promising MDR Reversal Agents.
Zhu J; Wang R; Lou L; Li W; Tang G; Bu X; Yin S
J Med Chem; 2016 Jul; 59(13):6353-69. PubMed ID: 27328029
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of Strychnos alkaloids as MDR reversal agents for cancer cell eradication.
Munagala S; Sirasani G; Kokkonda P; Phadke M; Krynetskaia N; Lu P; Sharom FJ; Chaudhury S; Abdulhameed MD; Tawa G; Wallqvist A; Martinez R; Childers W; Abou-Gharbia M; Krynetskiy E; Andrade RB
Bioorg Med Chem; 2014 Feb; 22(3):1148-55. PubMed ID: 24405813
[TBL] [Abstract][Full Text] [Related]
38. Discovery of potential anticancer multi-targeted ligustrazine based cyclohexanone and oxime analogs overcoming the cancer multidrug resistance.
Zha GF; Qin HL; Youssif BGM; Amjad MW; Raja MAG; Abdelazeem AH; Bukhari SNA
Eur J Med Chem; 2017 Jul; 135():34-48. PubMed ID: 28431353
[TBL] [Abstract][Full Text] [Related]
39. 5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells.
Bai Z; Liu X; Guan Q; Ding N; Wei Q; Tong B; Zhao M; Zhang W; Ma L
Chem Biol Interact; 2020 Jan; 315():108886. PubMed ID: 31682804
[TBL] [Abstract][Full Text] [Related]
40. Multidrug resistance reversal activity of key ningalin analogues.
Soenen DR; Hwang I; Hedrick MP; Boger DL
Bioorg Med Chem Lett; 2003 May; 13(10):1777-81. PubMed ID: 12729663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
